Cobalt is classified as “probably carcinogenic to humans” by the International Agency for Research on Cancer (IARC), placing it in Group 2A, one step below confirmed carcinogens. The U.S. National Toxicology Program similarly lists cobalt and cobalt compounds that release cobalt ions in the body as “reasonably anticipated to be a human carcinogen.” The risk depends heavily on the form of cobalt, how you’re exposed, and how much reaches your body.
How Cobalt Is Classified
Not all cobalt compounds carry the same level of concern. In its 2023 review, IARC broke cobalt down into categories. Cobalt metal and soluble cobalt salts received the Group 2A designation based on strong evidence from animal studies and mechanistic evidence showing DNA damage in human cells. Cobalt oxide, a less soluble form, was placed in Group 2B (“possibly carcinogenic”), a lower tier of concern. Several other cobalt compounds, including cobalt sulfide, were deemed “not classifiable” due to insufficient evidence.
The European Chemicals Agency took a slightly firmer stance in 2019, upgrading cobalt to category 1B, meaning it is presumed to have carcinogenic potential for humans. These classifications are based primarily on inhalation studies in rodents, where cobalt exposure caused lung tumors at a consistent and dose-dependent rate.
What Cobalt Does Inside Cells
Cobalt’s cancer-causing potential comes down to two things happening at once. First, cobalt generates reactive oxygen species, unstable molecules that damage DNA. Second, cobalt ions interfere with the cell’s ability to repair that DNA damage. This one-two punch, creating damage while simultaneously blocking the repair process, is what makes cobalt particularly concerning at sustained high exposures.
In animal studies, rats and mice inhaling cobalt sulfate developed tumors in the deep lung tissue (alveolar and bronchiolar regions) at rates well above control groups. These tumors appeared with a clear dose-response pattern: higher exposure concentrations produced more tumors in both sexes.
Occupational Exposure Carries the Clearest Risk
The strongest human evidence comes from workers in the hard-metal industry, where cobalt is mixed with tungsten carbide to make cutting tools, drill bits, and wear-resistant parts. A large study following workers in 10 French facilities from 1968 to 1991 found a statistically significant 30% increase in lung cancer deaths compared to the general population.
What made this study especially telling was the dose-response relationship. When researchers divided workers by cumulative exposure, the lung cancer risk climbed steadily: workers in the lowest exposure group had baseline risk, while those in the highest quartile had roughly four times the risk (odds ratio of 4.13). Duration mattered too, with risk nearly tripling after three decades of work in the industry.
Cobalt alone was part of the picture, but the combination of cobalt and tungsten carbide appeared to be especially dangerous. Workers exposed to both simultaneously had about twice the lung cancer risk (odds ratio of 1.93) compared to unexposed workers. Laboratory research explains why: tungsten carbide particles interact with cobalt metal in a way that dramatically increases the production of DNA-damaging oxygen species. The cobalt-tungsten carbide combination is essentially more than the sum of its parts.
Current U.S. workplace rules set the permissible exposure limit for cobalt dust and fumes at 0.1 milligrams per cubic meter of air over an 8-hour workday.
Hip Implants and Long-Term Exposure
Cobalt-chromium alloys are widely used in hip replacements, particularly in the femoral stem and the ball that fits into the socket. Over time, normal wear releases tiny metal particles and dissolved ions into surrounding tissue and the bloodstream. Studies confirm that blood and urine cobalt levels rise after hip replacement surgery.
A meta-analysis with a mean follow-up of 16 years found that patients with total hip replacements had roughly double the overall cancer risk compared to the general population. Metal-on-metal hip designs, which generate more cobalt and chromium debris than other designs, showed higher rates of prostate and skin cancer specifically. Statistically significant increases were also seen in blood cancers.
These findings don’t prove the implants directly caused the cancers, since people needing hip replacements may differ from the general population in other ways. But the pattern is consistent enough that it has driven the medical field away from metal-on-metal designs in recent years. Normal serum cobalt ranges from 0.1 to 1.2 micrograms per liter. If you have a cobalt-containing implant and experience unexplained symptoms, blood cobalt levels can help your doctor assess whether the implant is releasing excessive amounts of metal.
Food and Drinking Water Pose Little Risk
Cobalt occurs naturally in soil and water and is present in small amounts in many foods. It’s also the central atom in vitamin B12, which your body needs. The EPA reviewed available evidence on oral cobalt exposure and found no correlation between cobalt levels in drinking water and cancer deaths across U.S. communities. The one available study on oral exposure simply didn’t show a link.
This makes sense biologically. The cancer risk from cobalt is driven by direct, sustained contact with tissues, particularly lung tissue through inhalation. When cobalt passes through the digestive system, the exposure pattern is fundamentally different: lower concentrations, shorter contact time, and different absorption dynamics. For the vast majority of people whose cobalt exposure comes from diet alone, cancer risk from cobalt is not a practical concern.
Who Should Pay Attention
The people with meaningful cobalt-related cancer risk fall into specific groups. Workers in hard-metal manufacturing, diamond polishing, cobalt refining, and industries that grind or machine cobalt alloys face the highest inhalation exposures. Risk increases with years on the job and is amplified when cobalt is used alongside tungsten carbide. Proper ventilation, respiratory protection, and workplace air monitoring are the primary tools for reducing that risk.
People with metal-on-metal hip implants, particularly older designs, have a different but real exposure pathway. The elevated cancer rates seen in long-term follow-up studies are worth discussing with an orthopedic surgeon, especially if routine blood work shows rising cobalt levels or if you’re experiencing joint pain, swelling, or other signs of implant wear.